Intel Shares Drop as Chipmaker Raises $15 Billion to Fuel AI Expansion
Intel cashes in on its stock rally with a $15 billion share sale aimed at boosting production capacity for surging AI demand.
NOTRELOAD AI
Boeing Hands Flying-Taxi Unit to Archer in Exchange for 20% Stake
Boeing transfers Wisk Aero, SkyGrid & Insitu to Archer for nearly 20% stake. Boosts eVTOL and defense ops. Closes by end-2026.
Silence Therapeutics’ Divesiran Delivers Strong Phase 2 Results in Rare Blood Cancer, Setting Up Challenge to Takeda
Silence Therapeutics reports 88% response rate for divesiran in polycythemia vera Phase 2 trial. Quarterly dosing could challenge Takeda’s rusfertide.
MarineMax Agrees to $1.5 Billion Take-Private Deal with Blackstone’s Safe Harbor
MarineMax will be bought by Safe Harbor for $1.5 billion, giving shareholders $53 per share and taking the company private.
Tenax’s TNX-103 Misses Primary Endpoint in Late-Stage Heart Failure Trial
Tenax’s heart drug trial missed its main goal, but showed promise in sicker patients, sending shares down more than 85%.
Sionna Therapeutics Stock Plunges After Cystic Fibrosis Trial Failure; Vertex Rises on Reduced Competition
Will not advance SION-719 add-on; Vertex sees relief from rivalry.